Business profile not generated.
Run python -m application.cli.business_profile run --market US --one HEPA, then regenerate the site.
Issue 000 | U.S. Pilot | US
HEPA
Hepion Pharmaceuticals, Inc.
Passing
Verified
10-Q | 2026-05-14
Filing currency: USD
Margin of Safety
47.4%
GNNI internal calculation. Market context inputs are retained internally and are not displayed.
- Current Assets
- 2,705,503USD
- Total Liabilities
- 848,747USD
- NCAV
- 1,856,756USD
- Cash
- 2,602,580USD
- NCAV per share
- 0.16USD/share
- Evidence
- 10 annual | 20 quarterly
Business Profile
Checklist-driven facts extracted from filing text. Missing fields stay visible.
Known Unknowns
Medium | Share Count
Issue 000 does not yet evaluate share count trend or post-filing dilution beyond Mary's screening flags.
Low | Classification
U.S. Pilot rows are surfaced for source inspection and may still need manual business classification review.
Annual Financials
Latest annual periods, newest first. Missing cells render as n/a.
| Metric |
2025-12-31
10-K
USD
|
2024-12-31
10-K
USD
|
2023-12-31
10-K
USD
|
2022-12-31
10-K
USD
|
2021-12-31
10-K
USD
|
2020-12-31
10-K
USD
|
2019-12-31
10-K
USD
|
2018-12-31
10-K
USD
|
2017-06-30
10-K
USD
|
2016-06-30
10-K
USD
|
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | n/a | n/a | 0 | 0 | 0 | 0 | n/a | n/a | n/a | n/a |
| Operating Income | -4,163,691 | -19,346,578 | -48,447,954 | -45,488,726 | -30,403,309 | -20,146,075 | -7,770,085 | -14,594,159 | -21,023,872 | -20,805,485 |
| Net Income | -8,277,850 | -13,192,420 | -48,926,042 | -42,200,049 | -32,722,168 | -20,353,938 | -6,718,698 | -9,449,295 | -14,891,050 | -16,998,638 |
| Cash From Operations | -3,271,520 | -18,216,303 | -40,888,878 | -34,961,171 | -31,224,481 | -16,165,202 | -7,565,059 | -15,646,027 | -19,172,110 | -16,555,098 |
| Capex | n/a | n/a | -14,304 | -16,336 | -130,405 | -87,983 | -51,469 | n/a | -14,709 | -6,603 |
| Free Cash Flow | n/a | n/a | -40,903,182 | -34,977,507 | -31,354,886 | -16,253,185 | -7,616,528 | n/a | -19,186,819 | -16,561,701 |
| Cash And Equivalents | n/a | n/a | n/a | n/a | n/a | n/a | 13,922,972 | 2,832,429 | 12,982,748 | 7,403,940 |
| Accounts Receivable | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Inventory | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Current Assets | 3,069,952 | 1,613,737 | 17,487,840 | 56,496,073 | 97,451,768 | 42,634,299 | 14,388,665 | 2,968,020 | 13,192,922 | 7,894,985 |
| Total Assets | 3,069,952 | 1,613,737 | 18,094,397 | 60,244,452 | 103,552,479 | 48,645,253 | 20,432,607 | 8,189,172 | 18,384,592 | 13,106,712 |
| Total Current Liabilities | 299,383 | 3,143,886 | 5,290,096 | 7,885,722 | 8,206,396 | 4,661,827 | 1,251,889 | 2,849,849 | 2,944,874 | 5,083,547 |
| Total Liabilities | 402,405 | 3,477,075 | 10,813,590 | 10,388,515 | 10,557,476 | 8,124,862 | 4,247,015 | 6,214,121 | 9,326,725 | 11,789,132 |
| Shareholders Equity | 2,667,547 | -1,863,338 | 7,280,807 | 49,855,937 | 92,995,003 | 40,520,391 | 16,185,592 | 1,975,051 | 9,057,867 | 1,317,580 |
| Shares Outstanding | 11,620,317 | 139,168 | 4,818,733 | 76,229,617 | 76,225,254 | 32,025,153 | 3,760,225 | 16,608,512 | 75,707,348 | 22,276,730 |
| Shares Outstanding Diluted | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Weighted Avg Shares Diluted | 9,409,375 | 122,894 | 3,970,810 | 76,229,440 | 70,291,535 | 9,677,832 | n/a | 12,871,530 | 58,338,618 | 27,060,326 |
| Weighted Avg Shares Basic | 9,409,375 | 122,894 | 3,970,810 | 76,229,440 | 70,291,535 | 9,677,832 | 2,043,244 | 12,871,530 | 58,290,433 | 27,060,326 |
Quarterly Financials
Latest quarterly periods, newest first. Periods are shown only when Data Vault has them.
| Metric |
2026-03-31
10-Q
USD
|
2025-12-31
10-K
USD
|
2025-09-30
10-Q
USD
|
2025-06-30
10-Q
USD
|
2025-03-31
10-Q
USD
|
2024-12-31
10-K
USD
|
2024-09-30
10-Q
USD
|
2024-06-30
10-Q
USD
|
2024-03-31
10-Q
USD
|
2023-12-31
10-K
USD
|
2023-09-30
10-Q
USD
|
2023-06-30
10-Q
USD
|
2023-03-31
10-Q
USD
|
2022-12-31
10-K
USD
|
2022-09-30
10-Q
USD
|
2022-06-30
10-Q
USD
|
2022-03-31
10-Q
USD
|
2021-12-31
10-K
USD
|
2021-09-30
10-Q
USD
|
2021-06-30
10-Q
USD
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -798,509 | -609,683 | -527,902 | -1,745,511 | -1,280,595 | -1,202,154 | -4,458,259 | -8,503,848 | -5,182,317 | -10,408,594 | -10,664,565 | -14,165,630 | -13,209,165 | -9,772,811 | -8,465,326 | -19,998,121 | -7,252,468 | -8,999,891 | -8,517,356 | -6,854,599 |
| Net Income | -810,791 | -656,885 | -472,506 | -1,042,572 | -6,105,887 | -1,547,454 | -4,865,948 | -3,925,212 | -2,853,806 | -11,059,628 | -10,526,946 | -14,079,547 | -13,259,921 | -6,811,474 | -8,547,591 | -19,911,299 | -6,929,685 | -9,732,984 | -9,266,717 | -7,665,161 |
| Cash From Operations | 578,584 | -332,775 | -445,963 | -1,375,360 | -1,117,422 | -1,152,874 | -2,517,932 | -10,928,704 | -3,616,793 | -9,001,774 | -11,236,242 | -12,436,349 | -8,214,513 | -4,797,501 | -12,534,357 | -7,500,003 | -10,129,310 | -7,382,267 | -11,323,284 | -5,169,682 |
| Capex | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -348 | 2,582 | -16,538 | 0 | -16,336 | 0 | 0 | 0 | 1 | -36,486 | -11,815 |
| Free Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -9,002,122 | -11,233,660 | -12,452,887 | -8,214,513 | -4,813,837 | -12,534,357 | -7,500,003 | -10,129,310 | -7,382,266 | -11,359,770 | -5,181,497 |
| Cash And Equivalents | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Current Assets | 2,705,503 | 3,069,952 | 3,740,240 | 4,505,469 | 6,318,555 | 1,613,737 | 3,530,292 | 5,482,409 | 15,430,371 | 17,487,840 | 21,269,436 | 32,762,456 | 45,806,405 | 56,496,073 | 65,669,530 | 79,533,974 | 89,774,381 | 97,451,768 | 105,500,278 | 113,673,189 |
| Total Liabilities | 848,747 | 402,405 | 415,808 | 708,531 | 2,422,492 | 3,477,075 | 4,121,783 | 2,448,334 | 8,467,972 | 10,813,590 | 8,844,351 | 10,129,041 | 12,343,759 | 10,388,515 | 10,438,336 | 16,246,005 | 9,218,925 | 10,557,476 | 8,958,730 | 9,031,933 |
| Shares Outstanding | 11,620,317 | 11,620,317 | 11,620,317 | 11,620,317 | 9,588,908 | 139,168 | 6,958,371 | 5,799,126 | 5,473,126 | 4,818,733 | 3,838,289 | 3,838,289 | 3,811,482 | 76,229,617 | 76,229,617 | 76,229,617 | 76,229,617 | 76,225,254 | 76,225,254 | 76,225,245 |
| Shares Outstanding Diluted | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Weighted Avg Shares Diluted | 11,620,317 | 9,409,375 | 11,620,317 | 11,328,122 | 2,836,700 | 122,894 | 6,718,962 | 5,799,126 | 5,072,511 | 3,970,810 | 3,838,289 | 3,826,505 | 3,811,482 | 76,229,440 | 76,229,617 | 76,229,617 | 76,228,899 | 70,291,535 | 76,225,249 | 76,225,245 |
| Weighted Avg Shares Basic | 11,620,317 | 9,409,375 | 11,620,317 | 11,328,122 | 2,836,700 | 122,894 | 6,718,962 | 5,799,126 | 5,072,511 | 3,970,810 | 3,838,289 | 3,826,505 | 3,811,482 | 76,229,440 | 76,229,617 | 76,229,617 | 76,228,899 | 70,291,535 | 76,225,249 | 76,225,245 |
Audit Trail
NCAV Audit
Official-source inputs remain linked to filing provenance. Derived values are labeled as such.
| Input | Value | Source concept | Filing period | Confidence | Provenance |
|---|---|---|---|---|---|
| Current Assets | 2,705,503USD | us-gaap:AssetsCurrent | 2026-03-31 | 1.00 |
sec/companyfacts/cik=0001583771/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001583771\companyfacts.json |
| Total Liabilities | 848,747USD | us-gaap:Liabilities | 2026-03-31 | 1.00 |
sec/companyfacts/cik=0001583771/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001583771\companyfacts.json |
| Cash | n/a | derived | 2026-03-31 | n/a | n/a |
| Shares Outstanding | 11,620,317 | us-gaap:CommonStockSharesOutstanding | 2026-03-31 | 1.00 |
sec/companyfacts/cik=0001583771/companyfacts.json D:\Projects\The Data Vault\objects\sec\companyfacts\cik=0001583771\companyfacts.json |
| NCAV | 1,856,756USD | derived | 2026-03-31 | n/a | company-evidence-v1 | total_current_assets - total_liabilities |
| NCAV per share | 0.16USD | derived | 2026-03-31 | n/a | company-evidence-v1 | NCAV / shares_outstanding |
| Margin of Safety | 47.4% | derived | 2026-03-31 | n/a | gnni_publication_pack | internal_discount |
NCAV = total_current_assets - total_liabilities | NCAV per share = NCAV / shares_outstanding
Source Provenance
- Data Source
- Data Vault
- Data Vault Root
- CIK
- 0001583771
- Company ID
- n/a
- Selected Annual Source
- n/a
- Selected Quarterly Source
- n/a
- Statement Extractor
- companyfacts-screener-v1
- View Extractor
- companyfacts-screener-v1
- Source Accession Count
- 26
- Imported At
- 2026-07-04T23:04:31+00:00
- Rendered At
- 2026-07-05T09:06:29+00:00
Run Audit
- Mary Run
- 1ec055d81d1a42a39490a83bb9e1f22f
- Mary As Of
- 2026-07-03
- Accession
- 0001493152-26-023136
- CIK
- 0001583771
- Mary Filing Date
- 2026-05-14
- Filing Currency
- USD
- Internal Discount
- 47.4%
- Source State
- Verified
- Market Context
- Not Displayed
- Market Policy
- internal_only_not_redistributed
- Share Trend
- Not Evaluated
- Dilution
- Needs Review
mary_run=1ec055d81d1a42a39490a83bb9e1f22f; mary_as_of=2026-07-03; mary_filing_date=2026-05-14; mary_accession=0001493152-26-023136; mary_cik=0001583771; gnni_supporting_filing_date=2026-05-14; internal_discount=0.474295; mary_reason=Mary's deterministic net-net screen flagged this candidate. The internal discount is shown; raw market-data fields are not published in this pilot.